Evidence-informed health policy - the crucial role of advocacy

被引：12

作者：

Field, P. ^{[1
]}

Gauld, R. ^{[2
]}

Lawrence, M. ^{[3
]}

机构：

[1] Univ Otago, Dept Human Nutr, Dunedin, New Zealand

[2] Univ Otago, Dept Prevent & Social Med, Ctr Hlth Syst, Dunedin, New Zealand

[3] Deakin Univ, Sch Exercise & Nutr Sci, Food Policy Unit, WHO Collaborating Ctr Obes Prevent, Burwood, Vic, Australia

来源：

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2012年 / 66卷 / 04期

关键词：

BUY-IN; KNOWLEDGE; GOVERNMENT; NETWORKS;

D O I：

10.1111/j.1742-1241.2012.02883.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Health policy makers and clinicians often face similar decision-making challenges. The issues are turbulent, characterised by high risk and complexity, often involve value conflicts and occur in settings of rapid change. Policy makers' decisions are under increasing scrutiny for their use of evidence, with many health policies reflecting political influence rather than rigorous analysis. The evidence-based policy movement offers a range of accounts for this. We argue that advocacy in three critical areas helps explain when evidence is used in the policy making process and then contrast the impacts of advocacy for evidence use in two nutrition policy cases.

引用

页码：337 / 341

页数：5

共 24 条

[1] Vested Interests in Addiction Research and PolicyPoisonous partnerships: health sector buy-in to arrangements with government and addictive consumption industries [J].